Antibody to Nivolumab ELISA

Enzyme immunoassay for the semi-quantitative determination of free antibodies to Nivolumab (Opdivo®) in serum and plasma.

The solid phase (MTP) is coated by the drug Nivolumab. Due to the assay design this test only measures the free antibodies which are not bound to Nivolumab. Results are expressed in AU (arbitrary units).

Reference: IG-BB113

Barcode: 8699316552611

Legal Status: CE-Mark

Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

IG-BB113

Related Documents

 
 

Quality Control Certificates

Opdivo® is a trademark of Bristol Myers Squibb Company.

The Kit at a glance:

IG-BB113

Required Volume (µL) 10
Incubation Time (min) 135
Sample Serum or Plasma
Package Size 96 Tests
Results in Arbitrary Units (AU/mL)
Cut-Off (AU/mL) 3
Shelf Life (years) 2